Bronchiolitis Obliterans Syndrome Occurs Earlier in the Post-lung Allocation Score Era

Overview

Journal J Thorac Cardiovasc Surg

Specialties Cardiology & Vascular Diseases
General Surgery
Pulmonary Medicine

Date 2011 Feb 16

PMID 21320711

Citations 2

Authors

Abbas Emaminia

Sara A Hennessy

Tjasa Hranjec

Damien J LaPar

Benjamin D Kozower

David R Jones

Irving L Kron

Christine L Lau

Affiliations

Soon will be listed here.

Abstract

Objectives: In 2005, the time-based waiting list for lung transplantation was replaced by an illness/benefit lung allocation score (LAS). Although short-term outcomes after transplantation have been reported to be similar before and after the new system, little is known about long-term results. The objective of this study was to evaluate the impact of LAS on the development of bronchiolitis obliterans syndrome as well as on overall 3-year and bronchiolitis obliterans syndrome-related survival.

Methods: Data obtained from the United Network for Organ Sharing were used to review 8091 patients who underwent lung transplantation from 2002 to 2008. Patients were stratified according to time of transplantation into those treated before initiation of the LAS (pre-LAS group, January 2002-April 2005, n = 3729) and those treated after implementation of the score (post-LAS group, May 2005-May 2008, n = 4362). Overall, 3-year survivals for patient groups were compared using a univariate analysis, Cox proportional hazards model to generate a relative risk, and Kaplan-Meier curve analyses.

Results: During the 3-year follow-up period, bronchiolitis obliterans syndrome developed in 22% of lung transplant recipients (n = 1801). Although the incidence of postoperative bronchiolitis obliterans syndrome development was similar between groups, post-LAS patients incurred fewer bronchiolitis obliterans syndrome-free days (609 ± 7.5 vs 682 ± 9; P <.0001; log-rank test P = .0108) than did pre-LAS patients. Overall 3-year survival was lower in post-LAS patients and approached statistical significance (P = .05). Similarly, bronchiolitis obliterans syndrome-related survival was worse for patients in the post-LAS group (log-rank test P = .01).

Conclusions: In the current LAS era, lung transplant recipients have significantly fewer bronchiolitis obliterans syndrome-free days after 3-year follow-up. Compared with the pre-LAS population, overall and bronchiolitis obliterans syndrome-related survival appears worse in the post-LAS era. Limitation of known risk factors for development of bronchiolitis obliterans syndrome-may prove even more important in this patient population.

Citing Articles

Development of a Machine Learning-Powered Optimized Lung Allocation System for Maximum Benefits in Lung Transplantation: A Korean National Data.

Ha M, Cho W, So M, Lee D, Kim Y, Yeo H J Korean Med Sci. 2025; 40(7):e18.

PMID: 39995255 PMC: 11858608. DOI: 10.3346/jkms.2025.40.e18.

Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.

Kulkarni H, Cherikh W, Chambers D, Garcia V, Hachem R, Kreisel D J Heart Lung Transplant. 2018; 38(1):5-16.

PMID: 30391193 PMC: 6431291. DOI: 10.1016/j.healun.2018.09.016.

A review of bronchiolitis obliterans syndrome and therapeutic strategies.

Hayes Jr D J Cardiothorac Surg. 2011; 6:92.

PMID: 21767391 PMC: 3162889. DOI: 10.1186/1749-8090-6-92.

References

Yusen R, Shearon T, Qian Y, Kotloff R, Barr M, Sweet S . Lung transplantation in the United States, 1999-2008. Am J Transplant. 2010; 10(4 Pt 2):1047-68. DOI: 10.1111/j.1600-6143.2010.03055.x. View

Egan T, Kotloff R . Pro/Con debate: lung allocation should be based on medical urgency and transplant survival and not on waiting time. Chest. 2005; 128(1):407-15. DOI: 10.1378/chest.128.1.407. View

Daud S, Yusen R, Meyers B, Chakinala M, Walter M, Aloush A . Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med. 2006; 175(5):507-13. DOI: 10.1164/rccm.200608-1079OC. View

Christie J, Edwards L, Aurora P, Dobbels F, Kirk R, Rahmel A . The Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Lung and Heart-Lung Transplantation Report-2009. J Heart Lung Transplant. 2009; 28(10):1031-49. DOI: 10.1016/j.healun.2009.08.004. View

Fiser S, Kron I, LONG S, Kaza A, Kern J, Cassada D . Influence of graft ischemic time on outcomes following lung transplantation. J Heart Lung Transplant. 2001; 20(12):1291-6. DOI: 10.1016/s1053-2498(01)00355-2. View

Thabut G, Mal H, Cerrina J, Dartevelle P, Dromer C, Velly J . Graft ischemic time and outcome of lung transplantation: a multicenter analysis. Am J Respir Crit Care Med. 2005; 171(7):786-91. DOI: 10.1164/rccm.200409-1248OC. View

Russo M, Davies R, Hong K, Iribarne A, Kawut S, Bacchetta M . Who is the high-risk recipient? Predicting mortality after lung transplantation using pretransplant risk factors. J Thorac Cardiovasc Surg. 2009; 138(5):1234-1238.e1. PMC: 3073984. DOI: 10.1016/j.jtcvs.2009.07.036. View

McCue J, Mooney J, Quail J, Arrington A, Herrington C, Dahlberg P . Ninety-day mortality and major complications are not affected by use of lung allocation score. J Heart Lung Transplant. 2008; 27(2):192-6. DOI: 10.1016/j.healun.2007.11.001. View

Egan T, Murray S, Bustami R, Shearon T, McCullough K, Edwards L . Development of the new lung allocation system in the United States. Am J Transplant. 2006; 6(5 Pt 2):1212-27. DOI: 10.1111/j.1600-6143.2006.01276.x. View

10.

Ueno T, Snell G, Williams T, Kotsimbos T, Smith J, Rabinov M . Impact of graft ischemic time on outcomes after bilateral sequential single-lung transplantation. Ann Thorac Surg. 1999; 67(6):1577-82. DOI: 10.1016/s0003-4975(99)00309-4. View

11.

Chen H, Shiboski S, Golden J, Gould M, Hays S, Hoopes C . Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension. Am J Respir Crit Care Med. 2009; 180(5):468-74. PMC: 2742763. DOI: 10.1164/rccm.200810-1603OC. View

12.

Huang H, Yusen R, Meyers B, Walter M, Mohanakumar T, Patterson G . Late primary graft dysfunction after lung transplantation and bronchiolitis obliterans syndrome. Am J Transplant. 2008; 8(11):2454-62. PMC: 2678949. DOI: 10.1111/j.1600-6143.2008.02389.x. View

13.

Arcasoy S, Kotloff R . Lung transplantation. N Engl J Med. 1999; 340(14):1081-91. DOI: 10.1056/NEJM199904083401406. View

14.

Botha P, Archer L, Anderson R, Lordan J, Dark J, Corris P . Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome. Transplantation. 2008; 85(5):771-4. DOI: 10.1097/TP.0b013e31816651de. View

15.

Liu V, Zamora M, Dhillon G, Weill D . Increasing lung allocation scores predict worsened survival among lung transplant recipients. Am J Transplant. 2010; 10(4):915-920. PMC: 2860663. DOI: 10.1111/j.1600-6143.2009.03003.x. View

16.

Belperio J, Samuel Weigt S, Fishbein M, Lynch 3rd J . Chronic lung allograft rejection: mechanisms and therapy. Proc Am Thorac Soc. 2009; 6(1):108-21. DOI: 10.1513/pats.200807-073GO. View

17.

Trulock E, Edwards L, Taylor D, Boucek M, Keck B, Hertz M . Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult lung and heart-lung transplant report--2005. J Heart Lung Transplant. 2005; 24(8):956-67. DOI: 10.1016/j.healun.2005.05.019. View

18.

Verleden G, Vos R, De Vleeschauwer S, Willems-Widyastuti A, Verleden S, Dupont L . Obliterative bronchiolitis following lung transplantation: from old to new concepts?. Transpl Int. 2009; 22(8):771-9. DOI: 10.1111/j.1432-2277.2009.00872.x. View

19.

Hennessy S, Hranjec T, Swenson B, Kozower B, Jones D, Ailawadi G . Donor factors are associated with bronchiolitis obliterans syndrome after lung transplantation. Ann Thorac Surg. 2010; 89(5):1555-62. PMC: 3033807. DOI: 10.1016/j.athoracsur.2010.01.060. View

20.

Merlo C, Weiss E, Orens J, Borja M, Diener-West M, Conte J . Impact of U.S. Lung Allocation Score on survival after lung transplantation. J Heart Lung Transplant. 2009; 28(8):769-75. DOI: 10.1016/j.healun.2009.04.024. View